Health News
2006-04-04
FDA approves
generic AZT for U.S. sale
Approval allows
first foreign-made generic anti-HIV drug in U.S. market.
The Food and Drug
Administrat
The Food and Drug
Administration on Friday granted approval to a generic
version of AZT made by Indian drugmaker Aurobindo Pharma for
sale in the United States. The approval marks the
first time a generic anti-HIV medication made by a
foreign firm has been approved for U.S. sale. The U.S.
patent on AZT, sold under the brand name Retrovir, expired
in September. Aurobindo Pharma's cheaper version of
the medication is expected to be available in the
U.S. later this month. (The Advocate)
Click here to follow The Advocate on Twitter.
Page 1 of 1